107 related articles for article (PubMed ID: 17169375)
1. Serum levels of soluble CD95 are not associated with amelioration of multiple sclerosis during pregnancy.
Ehrlich S; Haas J; Zipp F; Infante-Duarte C
J Neurol Sci; 2007 Jan; 252(1):83-7. PubMed ID: 17169375
[TBL] [Abstract][Full Text] [Related]
2. CD95/Fas expression on peripheral blood T lymphocytes in patients with multiple sclerosis: effect of high-dose methylprednisolone therapy.
Petelin Z; Brinar V; Petravic D; Zurak N; Dubravcic K; Batinic D
Clin Neurol Neurosurg; 2004 Jun; 106(3):259-62. PubMed ID: 15177780
[TBL] [Abstract][Full Text] [Related]
3. Increased serum levels of soluble CD95 (APO-1/Fas) in relapsing-remitting multiple sclerosis.
Zipp F; Weller M; Calabresi PA; Frank JA; Bash CN; Dichgans J; McFarland HF; Martin R
Ann Neurol; 1998 Jan; 43(1):116-20. PubMed ID: 9450777
[TBL] [Abstract][Full Text] [Related]
4. Is the modulatory effect of pregnancy in multiple sclerosis associated with changes in blood apoptotic molecules?
Rinta S; Airas L; Elovaara I
Acta Neurol Scand; 2010 Sep; 122(3):168-74. PubMed ID: 20695850
[TBL] [Abstract][Full Text] [Related]
5. Serum levels of sTNFR-1 and sFas in patients with relapsing-remitting multiple sclerosis.
Bilińska M; Frydecka I; Podemski R; Gruszka E
Med Sci Monit; 2002 Oct; 8(10):CR720-3. PubMed ID: 12388926
[TBL] [Abstract][Full Text] [Related]
6. Level of sFas/APO 1 in serum and cerebrospinal fluid in multiple sclerosis.
Mahovic D; Petravic D; Petelin Z; Zurak N; Horvat G; Hajnsek S
Clin Neurol Neurosurg; 2004 Jun; 106(3):230-2. PubMed ID: 15177773
[TBL] [Abstract][Full Text] [Related]
7. Effects of sex hormones on costimulatory molecule expression in multiple sclerosis.
Pelfrey CM; Moldovan IR; Cotleur AC; Zamor N; Rudick RA
J Neuroimmunol; 2005 Oct; 167(1-2):190-203. PubMed ID: 16046001
[TBL] [Abstract][Full Text] [Related]
8. Soluble FAS (CD95) is not elevated in the serum of patients with myeloid leukemias, myeloproliferative and myelodysplastic syndromes.
Munker R; Midis G; Owen-Schaub L; Andreff M
Leukemia; 1996 Sep; 10(9):1531-3. PubMed ID: 8751476
[TBL] [Abstract][Full Text] [Related]
9. CSF levels of soluble HLA-G and Fas molecules are inversely associated to MRI evidence of disease activity in patients with relapsing-remitting multiple sclerosis.
Fainardi E; Rizzo R; Melchiorri L; Stignani M; Castellazzi M; Tamborino C; Paolino E; Tola MR; Granieri E; Baricordi OR
Mult Scler; 2008 May; 14(4):446-54. PubMed ID: 18208868
[TBL] [Abstract][Full Text] [Related]
10. Apoptosis of T cells in peripheral blood and cerebrospinal fluid is associated with disease activity of multiple sclerosis.
Okuda Y; Apatoff BR; Posnett DN
J Neuroimmunol; 2006 Feb; 171(1-2):163-70. PubMed ID: 16290072
[TBL] [Abstract][Full Text] [Related]
11. Evolution of soluble forms of CD86, CD95 and CD95L molecules in liver transplant recipients.
Marín LA; Moya-Quiles MR; Miras M; Minguela A; Bermejo J; Ramírez P; García-Alonso AM; Parrilla P; Alvarez-López MR; Muro M
Transpl Immunol; 2012 Mar; 26(2-3):94-100. PubMed ID: 22182632
[TBL] [Abstract][Full Text] [Related]
12. Plasma levels of soluble adhesion molecules sPECAM-1, sP-selectin and sE-selectin are associated with relapsing-remitting disease course of multiple sclerosis.
Kuenz B; Lutterotti A; Khalil M; Ehling R; Gneiss C; Deisenhammer F; Reindl M; Berger T
J Neuroimmunol; 2005 Oct; 167(1-2):143-9. PubMed ID: 16040131
[TBL] [Abstract][Full Text] [Related]
13. Circulating levels of soluble apoptosis-related molecules in patients with multiple sclerosis.
Moreno M; Sáenz-Cuesta M; Castilló J; Cantó E; Negrotto L; Vidal-Jordana A; Montalban X; Comabella M
J Neuroimmunol; 2013 Oct; 263(1-2):152-4. PubMed ID: 23932896
[TBL] [Abstract][Full Text] [Related]
14. Atorvastatin does not alter serum levels of sCD95 and sCD95L in multiple sclerosis.
Sellner J; Greeve I; Findling O; Grandgirard D; Leib SL; Mattle HP
Clin Exp Immunol; 2008 May; 152(2):280-4. PubMed ID: 18341614
[TBL] [Abstract][Full Text] [Related]
15. Treating autoimmune demyelination by augmenting lymphocyte apoptosis in the central nervous system.
Pender MP
J Neuroimmunol; 2007 Nov; 191(1-2):26-38. PubMed ID: 17931708
[TBL] [Abstract][Full Text] [Related]
16. Soluble Fas and soluble FasL in multiple organ dysfunction syndrome complicating diffuse peritonitis.
Kitamura M; Endo S; Sato N; Yaegashi Y; Suxzuki Y; Kojika N; Wakabayashi G
Res Commun Mol Pathol Pharmacol; 2004; 115-116():235-42. PubMed ID: 17564320
[TBL] [Abstract][Full Text] [Related]
17. Significance of serum-soluble CD95 (Fas/APO-1) on prognosis in renal cell cancer patients.
Kimura M; Tomita Y; Imai T; Saito T; Katagiri A; Tanikawa T; Takeda M; Takahashi K
Br J Cancer; 1999 Jul; 80(10):1648-51. PubMed ID: 10408413
[TBL] [Abstract][Full Text] [Related]
18. Soluble MHC class I chain-related protein B serum levels correlate with disease activity in relapsing-remitting multiple sclerosis.
Fernández-Morera JL; Rodríguez-Rodero S; Lahoz C; Tuñon A; Astudillo A; Garcia-Suarez O; Martínez-Borra J; López-Vázquez A; Rodrigo L; Gonzalez S; López-Larrea C
Hum Immunol; 2008; 69(4-5):235-40. PubMed ID: 18486757
[TBL] [Abstract][Full Text] [Related]
19. Impaired expression of peripheral blood apoptotic-related gene transcripts in acute multiple sclerosis relapse.
Achiron A; Feldman A; Mandel M; Gurevich M
Ann N Y Acad Sci; 2007 Jun; 1107():155-67. PubMed ID: 17804543
[TBL] [Abstract][Full Text] [Related]
20. Postpartum-activation of multiple sclerosis is associated with down-regulation of tolerogenic HLA-G.
Airas L; Nikula T; Huang YH; Lahesmaa R; Wiendl H
J Neuroimmunol; 2007 Jul; 187(1-2):205-11. PubMed ID: 17561269
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
